The best indicator for Jack Henry & Associates (JKHY)
We backtested 20 indicators across daily, weekly and hourly charts on real Jack Henry & Associates (JKHY) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
EMA 20/50 Cross
On the weekly chart, this is the strongest risk-adjusted edge we found for Jack Henry & Associates (JKHY) over ~40.7 years — trailing buy-and-hold by 4.7% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | EMA 20/50 Cross ✓ | Weekly | 12.2% | 0.53 | -68.4% | 41.2% | 17 | -4.7% |
| 2 | SMA 50/200 Cross ✓ | Daily | 12.5% | 0.52 | -58.7% | 53.8% | 26 | -4.4% |
| 3 | EMA 50/200 Cross ✓ | Daily | 11.6% | 0.5 | -75.8% | 44.0% | 25 | -5.2% |
| 4 | Bollinger Mean-Reversion ✓ | Daily | 8.9% | 0.44 | -65.5% | 63.6% | 162 | -8.0% |
| 5 | Donchian Midline ✓ | Weekly | 9.2% | 0.44 | -66.3% | 47.1% | 119 | -7.7% |
| 6 | EMA 20/50 Cross ✓ | Daily | 8.6% | 0.42 | -74.7% | 38.0% | 92 | -8.3% |
| 7 | Stochastic ✓ | Daily | 8.6% | 0.42 | -56.9% | 63.5% | 170 | -8.2% |
| 8 | RSI Trend (>50) ✓ | Weekly | 8.0% | 0.41 | -86.9% | 43.0% | 121 | -8.9% |
| 9 | ADX / DMI ✓ | Weekly | 7.2% | 0.41 | -64.3% | 46.8% | 62 | -9.7% |
| 10 | EMA-10 Trend ✓ | Weekly | 7.9% | 0.41 | -72.3% | 45.8% | 192 | -9.0% |
| 11 | Donchian Breakout | Weekly | 7.5% | 0.4 | -71.9% | 48.6% | 37 | -9.4% |
| 12 | Williams %R ✓ | Daily | 7.5% | 0.38 | -76.7% | 65.0% | 263 | -9.4% |
| 13 | Bollinger Mean-Reversion ✓ | Weekly | 7.0% | 0.38 | -59.1% | 80.6% | 31 | -9.9% |
| 14 | Holy Grail Confluence ✓ | Daily | 6.7% | 0.36 | -60.9% | 70.2% | 57 | -10.1% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Jack Henry & Associates (JKHY), EMA 20/50 Cross on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.